Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

BACKGROUND: The purpose of this study was to determine if eyes with diabetic macular edema (DME) unresponsive to ranibizumab or bevacizumab would benefit from conversion to aflibercept. METHODS: This study was conducted as a retrospective chart review of subjects with DME unresponsive to ranibizumab...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Ophthalmol
Hoofdauteurs: Lim, Laurence S, Ng, Wei Yan, Mathur, Ranjana, Wong, Doric, Wong, Edmund YM, Yeo, Ian, Cheung, Chui Ming Gemmy, Lee, Shu Yen, Wong, Tien Yin, Papakostas, Thanos D, Kim, Leo A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2015
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577250/
https://ncbi.nlm.nih.gov/pubmed/26396494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S81523
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items